Less May Be More When It Comes to Surgery for Early-Stage Lung Cancer
FRIDAY, Feb. 10, 2023 (HealthDay News) — Some patients having surgery for early-stage lung cancer may no longer need to lose an entire lobe of their lung, new research shows.The study results are from a phase 3 clinical trial sponsored by the Allianc…
Learn MoreThis Super Bowl, Keep Little Hands From Tip-Over TVs
FRIDAY, Feb. 10, 2023 (HealthDay News) — Watching the big game on a big TV? Keep safety in mind if young children are around.Seven of 10 fatal furniture tip-over incidents in children involve a falling television, the U.S. Consumer Product Safety Com…
Learn MoreSuicide Rates Up for Most Race, Ethnic Groups in 2018 to 2021
THURSDAY, Feb. 9, 2023 (HealthDay News) — From 2018 to 2021, age-adjusted suicide rates increased among most race/ethnic groups, according to research published in the Feb. 10 issue of the U.S. Centers for Disease Control and Prevention Morbidity an…
Learn MoreCould a Vibrating Pill Ease Chronic Constipation?
THURSDAY, Feb. 9, 2023 (HealthDay News) — A new treatment for chronic constipation may bring relief without having to use drugs. It is a vibrating pill called Vibrant that stimulates the colon as it passes through the body. Although the pill was appr…
Learn MorePegylated Interferon Lambda Effective in Preventing Severe COVID-19
THURSDAY, Feb. 9, 2023 (HealthDay News) — For a predominantly vaccinated adult population with COVID-19, the incidence of hospitalization or emergency department visit is significantly lower for those receiving a single dose of pegylated interferon l…
Learn MoreSublobar Resection Not Inferior to Lobar Resection for T1aN0 NSCLC
THURSDAY, Feb. 9, 2023 (HealthDay News) — Sublobar resection is not inferior to lobar resection for patients with peripheral non-small cell lung cancer (NSCLC) with a tumor size of 2 cm or less, according to a study published in the Feb. 9 issue of t…
Learn MoreDifelikefalin Improves Itch Intensity in Notalgia Paresthetica
THURSDAY, Feb. 9, 2023 (HealthDay News) — Oral treatment with difelikefalin results in greater reductions in itch intensity scores than placebo among patients with notalgia paresthetica, but it does not improve secondary outcomes, according to a stud…
Learn MoreASA: Sex Differences Seen in Use of Dual Antiplatelet Therapy After Minor Stroke
THURSDAY, Feb. 9, 2023 (HealthDay News) — Dual antiplatelet therapy (DAPT) is underused following transient ischemic attack (TIA) and minor acute ischemic stroke (AIS), particularly in women, according to a study presented at the annual American Stro…
Learn MoreASA: Sex Differences Seen in Use of Dual Antiplatelet Therapy After Minor Stroke
THURSDAY, Feb. 9, 2023 (HealthDay News) — Dual antiplatelet therapy (DAPT) is underused following transient ischemic attack (TIA) and minor acute ischemic stroke (AIS), particularly in women, according to a study presented at the annual American Stro…
Learn MoreScientists Devise Way to Keep Donor Hearts Viable Longer
THURSDAY, Feb. 9, 2023 (HealthDay News) — Doctors have discovered a way to extend the short shelf life of donor hearts, which could hopefully make more of the organs available to desperate recipients.Valproic acid (Depakote), which is approved to tre…
Learn More